Science Magazine to Host Webinar on Advances in Cance... ( The business...)

Science Magazine to Host Webinar on Advances in Cancer Genomics

Date:4/15/2009

The business office of Science, the world's leading peer-reviewed research journal, is partnering with Applied Biosystems, a division of Life Technologies Corporation, to produce a webinar on Advances in Cancer Genomics to be broadcast live online at 12 noon ET (4:00 GMT) April 30, 2009.

(PRWEB) April 15, 2009 -- The business office of Science, the world's leading peer-reviewed research journal, is partnering with Applied Biosystems, a division of Life Technologies Corporation, to produce a webinar on Advances in Cancer Genomics to be broadcast live online at 12 noon ET (4:00 GMT) April 30, 2009.

The webinar will feature a discussion of the latest advances in cancer genomics by a panel of experts including Sean Grimmond, Ph.D. of the Institute for Molecular Bioscience at the University of Queensland, Australia; David Wheeler, Ph.D., of the Baylor College of Medicine in Houston, Texas; and John McPherson, Ph.D., of the Ontario Institute for Cancer Research in Toronto, Canada and moderated by Sean Sanders, Ph.D., the Commercial Editor for Science.

Cancer is a complex family of diseases, characterized by the deregulation or dysregulation of the normal control pathways for cellular growth and/or cell death. Despite advances, technological limitations or excessive cost have historically restricted research into causative factors. Next-generation genomic platforms now are enabling scientists to study individual genomes in more depth, giving them a better understanding of the mechanisms of tumorigenesis, metastasis, and therapeutic response.

"Obtaining fundamental sequence data from both tumor and normal tissue is essential for understanding the pathways that lead to cancer," says Dr. Sanders. "With this information in hand, the multitude of subtle genetic changes that allow for cancer initiation and progression can be uncovered."

During this webin
'/>"/>

3

GOOD

Page: 1 2 3
Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
7. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
8. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
9. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER

Post Your Comments:

Science Magazine to Host Webinar on Advances in Cance...( The business...)